-
Signature
-
YuFan Stephanie Wang, Attorney-in-Fact
-
Stock symbol
-
PRGS
-
Transactions as of
-
Apr 20, 2023
-
Transactions value $
-
-$1,244,139
-
Form type
-
4
-
Date filed
-
4/24/2023, 04:28 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
PRGS |
Common Stock |
Options Exercise |
$687K |
+23.5K |
+122.17% |
$29.25 |
42.7K |
Apr 20, 2023 |
Direct |
|
transaction |
PRGS |
Common Stock |
Sale |
-$1.33M |
-23.5K |
-54.99% |
$56.58 |
19.2K |
Apr 20, 2023 |
Direct |
F1, F2 |
transaction |
PRGS |
Common Stock |
Options Exercise |
$673K |
+13.3K |
+69.02% |
$50.69 |
32.5K |
Apr 20, 2023 |
Direct |
|
transaction |
PRGS |
Common Stock |
Sale |
-$751K |
-13.3K |
-40.84% |
$56.57 |
19.2K |
Apr 20, 2023 |
Direct |
F1, F3 |
transaction |
PRGS |
Common Stock |
Sale |
-$524K |
-9.27K |
-48.2% |
$56.57 |
9.96K |
Apr 20, 2023 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
PRGS |
Employee Stock Options |
Options Exercise |
$0 |
-23.5K |
-100% |
$0.00* |
0 |
Apr 20, 2023 |
Common Stock |
23.5K |
$29.25 |
Direct |
F5 |
transaction |
PRGS |
Employee Stock Options |
Options Exercise |
$0 |
-13.3K |
-100% |
$0.00* |
0 |
Apr 20, 2023 |
Common Stock |
13.3K |
$50.69 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: